stocks logo

MRVI Financial Analysis

Maravai LifeSciences Holdings Inc
$
1.770
+0.050(+2.910%)

MRVI Financial Analysis

FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4
Total Revenue
65.20M
-2.49%
73.40M
6.51%
64.18M
-18.79%
74.14M
-63.78%
66.87M
-65.04%
68.91M
-71.61%
79.03M
-67.65%
204.71M
-10.39%
191.26M
-6.61%
242.73M
11.46%
244.29M
64.83%
228.44M
132.27%
204.81M
217.78M
148.21M
98.35M
173.51%
Revenue from Goods & Services
65.20M
-2.49%
73.40M
6.51%
64.18M
-18.79%
74.14M
-63.78%
66.87M
-65.04%
68.91M
-71.61%
79.03M
-67.65%
204.71M
-10.39%
191.26M
-6.61%
242.73M
11.46%
244.29M
64.83%
228.44M
132.27%
204.81M
217.78M
148.21M
98.35M
173.51%
Cost of Goods Sold
36.83M
0.38%
38.27M
-11.56%
38.34M
13.83%
35.11M
-34.07%
36.69M
-3.90%
43.27M
15.41%
33.68M
-15.88%
53.25M
31.06%
38.18M
18.48%
37.50M
-0.83%
40.03M
27.53%
40.63M
73.68%
32.22M
37.81M
31.39M
23.40M
31.21%
Gross Profit
28.37M
-5.98%
35.13M
37.00%
25.84M
-43.01%
39.03M
-74.23%
30.18M
-80.29%
25.64M
-87.51%
45.35M
-77.80%
151.46M
-19.36%
153.09M
-11.30%
205.24M
14.04%
204.26M
74.85%
187.81M
150.55%
172.59M
179.96M
116.82M
74.96M
313.45%
Selling General & Administrative Expenses
43.43M
0.51%
45.84M
15.84%
45.92M
7.24%
43.07M
2.03%
43.21M
19.42%
39.57M
22.38%
42.82M
16.05%
42.21M
14.94%
36.18M
27.15%
32.34M
22.35%
36.90M
43.95%
36.73M
-15.98%
28.46M
26.43M
25.63M
43.71M
160.77%
Research & Development Expense
4.34M
-0.07%
5.28M
25.99%
5.03M
21.40%
3.99M
-9.45%
4.35M
-19.34%
4.19M
-1.87%
4.15M
12.18%
4.41M
-48.55%
5.39M
176.93%
4.27M
121.57%
3.70M
71.06%
8.57M
4365.10%
1.95M
1.93M
2.16M
192.00K
-80.39%
Other Operating Expense - Net
-2.70M
-32.80%
-1.45M
-64.31%
-2.93M
-53.20%
-4.36M
7.18%
-4.02M
45.10%
-4.07M
31.40%
-6.27M
4.99%
-4.07M
421.82%
-2.77M
-902.03%
-3.10M
-423.85%
-5.97M
552.13%
-779.00K
345.00K
956.00K
-915.00K
0.00
Operating Profit
-12.36M
37.06%
-9.26M
-6.11%
-17.14M
-294.83%
318.00K
-99.72%
-9.02M
-107.53%
-9.86M
-105.60%
8.80M
-94.92%
113.31M
-25.39%
119.67M
-16.77%
176.00M
15.35%
173.33M
88.19%
151.86M
386.04%
143.79M
152.58M
92.10M
31.25M
2185.66%
Financing Income- Net
-6.56M
56.08%
-4.85M
2000.87%
-3.65M
-36.87%
-7.94M
1.26%
-4.21M
34.09%
-231.00K
-94.79%
-5.79M
117.27%
-7.84M
76.90%
-3.14M
-59.19%
-4.43M
-42.03%
-2.66M
-66.30%
-4.43M
-49.66%
-7.69M
-7.65M
-7.90M
-8.81M
14.08%
Interest Expense
6.56M
56.08%
4.85M
2000.87%
3.65M
-36.87%
7.94M
1.26%
4.21M
34.09%
231.00K
-94.79%
5.79M
117.27%
7.84M
76.90%
3.14M
-59.19%
4.43M
-42.03%
2.66M
-66.30%
4.43M
-49.66%
7.69M
7.65M
7.90M
8.81M
14.08%
Other Non-Operating Income
33.00K
-103.51%
-2.56M
68.66%
106.00K
-108.36%
671.28M
-12243.22%
-941.00K
23425.00%
-1.52M
19.14%
-1.27M
-154.03%
-5.53M
95.34%
-4.00K
-100.12%
-1.28M
42400.00%
2.35M
-60.15%
-2.83M
47066.67%
3.32M
-3.00K
5.89M
-6.00K
-126.09%
Income before Taxes
-175.64M
754.17%
-16.93M
26.66%
-22.41M
395.45%
656.19M
584.41%
-20.56M
-118.08%
-13.36M
-107.64%
-4.52M
-102.71%
95.88M
-33.34%
113.76M
-24.67%
174.99M
19.95%
166.84M
87.10%
143.82M
869.09%
151.02M
145.88M
89.17M
14.84M
-331.53%
Income Taxes
311.00K
-105.69%
-2.44M
71.36%
271.00K
-108.54%
766.17M
8970.30%
-5.46M
-138.70%
-1.42M
-107.78%
-3.18M
-115.89%
8.45M
-51.95%
14.11M
-25.11%
18.27M
60.47%
19.98M
45.75%
17.58M
4663.69%
18.84M
11.39M
13.71M
369.00K
-138.44%
Net Income after Tax
-175.96M
1065.11%
-14.49M
21.34%
-22.68M
1582.49%
-109.98M
-225.80%
-15.10M
-115.15%
-11.94M
-107.62%
-1.35M
-100.92%
87.43M
-30.75%
99.65M
-24.61%
156.72M
16.52%
146.86M
94.61%
126.24M
772.33%
132.18M
134.50M
75.47M
14.47M
-365.54%
Minority Interest
-76.92M
790.24%
-6.91M
27.86%
-10.60M
727.63%
-4.02M
-108.08%
-8.64M
-115.66%
-5.40M
-106.32%
-1.28M
-101.60%
49.80M
-29.67%
55.18M
-29.45%
85.48M
0.15%
80.00M
52.78%
70.80M
-857.33%
78.22M
85.35M
52.36M
-9.35M
1792.51%
Income Available to Common Shares
-99.04M
1432.62%
-7.59M
15.96%
-12.08M
17926.87%
-105.96M
-381.55%
-6.46M
-114.53%
-6.54M
-109.18%
-67.00K
-100.10%
37.63M
-32.12%
44.47M
-17.59%
71.24M
44.96%
66.86M
189.42%
55.44M
137.37%
53.96M
49.14M
23.10M
23.36M
-465.62%
EPS - Basic
-0.70
1300.00%
-0.06
20.00%
-0.09
-0.80
-375.86%
-0.05
-114.71%
-0.05
-109.26%
0.00
-100.00%
0.29
-30.95%
0.34
-26.09%
0.54
22.73%
0.51
112.50%
0.42
366.67%
0.46
0.44
0.24
0.09
-550.00%
EPS - Diluted
-0.70
1300.00%
-0.06
20.00%
-0.09
-0.80
-240.35%
-0.05
-114.71%
-0.05
-109.43%
0.00
-100.00%
0.57
32.56%
0.34
-22.73%
0.53
20.45%
0.50
108.33%
0.43
616.67%
0.44
0.44
0.24
0.06
-400.00%
EBIT
-12.36M
37.06%
-9.26M
-6.11%
-17.14M
-294.83%
318.00K
-99.72%
-9.02M
-107.53%
-9.86M
-105.60%
8.80M
-94.92%
113.31M
-25.39%
119.67M
-16.77%
176.00M
15.35%
173.33M
88.19%
151.86M
386.04%
143.79M
152.58M
92.10M
31.25M
2185.66%
EBITDA
-424.00K
-121.70%
3.17M
-2253.74%
-5.49M
-131.03%
11.15M
-90.82%
1.95M
-98.47%
-147.00K
-100.08%
17.68M
-90.22%
121.51M
-19.99%
127.83M
-14.89%
184.19M
15.67%
180.72M
83.65%
151.86M
308.57%
150.19M
159.23M
98.40M
37.17M
364.51%
Depreciation Depletion & Amortization
11.94M
8.79%
12.43M
27.90%
11.66M
31.25%
10.83M
32.13%
10.97M
34.50%
9.72M
18.59%
8.88M
20.29%
8.20M
8.16M
27.43%
8.19M
23.10%
7.38M
17.23%
0.00
-100.00%
6.40M
6.66M
6.30M
5.93M
-10.70%

MRVI FAQs

What is MRVI's PE Ratio in 2025/4/15?

MRVI's PE ratio in April 15, 2025 is -1.65. This indicates the price investors are willing to pay for $1 of earnings.

What is MRVI's PS Ratio in 2025/4/15?

What is MRVI's Dividend Yield in 2024/Q4?

What is MRVI's Gross Margin in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is MRVI earnings result positive or negative?How should I trade on MRVI earnings?